Trying to separate three different claims about phenylpiracetam: that it is the right molecule, that it is the right dose, and that it does something useful.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
Happy to be corrected on any of the above.
Same here.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Not on phenylpiracetam but the pattern is familiar.
A certificate of analysis answers one question and gets quoted as though it answers four.
A certificate of analysis answers one question and gets quoted as though it answers four.
How long before you can reasonably say something is or is not doing anything?
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing. A fortnight in on phenylpiracetam and it lines up.
Reconstitution arithmetic is only half the problem. The other half is what was in the vial.
How long before you can reasonably say something is or is not doing anything? A fortnight in on phenylpiracetam and it lines up.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Same here.
Stupid question: how do you know whether what is in the vial matches the label at all?
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
Stupid question: how do you know whether what is in the vial matches the label at all?
Baseline first. Without a baseline the after picture is decoration. Vivid dreams was my main issue with phenylpiracetam too.